Versant Venture Capital VI, L.P. Insider Trading Activity

Average Profitability
0.91%
Insider Buys Quantity
6
Insider Buys Sum
$65.9M
Insider Sells Quantity
58
Insider Sells Sum
$62.42M

Insider Activity of Versant Venture Capital VI, L.P.

Biography of Versant Venture Capital VI, L.P.

No biography is available at this moment.

2025-09-30SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
224,974
2.191%
$46.01$10.35M-78.81%
2025-09-18SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
135,304
1.2095%
$42.23$5.71M-73.61%
2025-08-26SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
70,811
0.5847%
$39.01$2.76M-66.82%
2025-08-25SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
78,237
0.6548%
$39.54$3.09M-67.54%
2025-08-22SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
39,046
0.3318%
$40.15$1.57M-67.59%
2025-08-18SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
45,713
0.3731%
$38.56$1.76M-65.9%
2025-08-15SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
215,000
1.7975%
$39.50$8.49M-64.33%
2025-07-10SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
191,376
1.3772%
$34.00$6.51M-50.7%
2025-06-27SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
200,000
1.2896%
$30.46$6.09M-39.65%
2025-06-20SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
234,801
1.5054%
$30.29$7.11M-35.09%
2025-06-18SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
100,000
0.6339%
$29.95$3M-35.13%
2025-06-10SaleLENZ Therapeutics, Inc.
LENZ
10 percent owner
350,000
2.1483%
$29.00$10.15M-18.2%
2024-10-29SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
67,905
0.1081%
$9.16$621,801-39.11%
2024-10-28SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
89,990
0.2667%
$9.66$869,240-39.82%
2024-09-20SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.13M
1.8595%
$6.53$7.4M-16.82%
2024-09-13SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
9,269
0.0153%
$6.16$57,100-11.35%
2024-09-12SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
16,047
0.0263%
$6.00$96,309-9.06%
2024-09-11SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
541,897
0.833%
$6.00$3.25M-12.38%
2024-08-28SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
221,600
0.3894%
$6.32$1.4M-61.22%
2024-08-12SaleTempest Therapeutics, Inc.
TPST
10 percent owner
387,999
2.043%
$1.10$426,993-11.9%
Total: 53
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.